Differential response of HER2 positive breast cancer based on HER2 protein expression level

被引：0
|
作者：
Atallah, N. M. [1 ]
Toss, M. S. [2 ]
Al Saleem, M. [1 ]
Green, A. R. [3 ]
Mongan, N. P. [4 ]
Rakha, E. A. [5 ]
机构：
[1] Univ Nottingham, Nottingham, England
[2] Sheffield Teaching Hosp NHS Fdn Trust, Royal Hallamshire Hosp, Histopathol Dept 4, Sheffield, England
[3] Univ Nottingham, Biodiscovery Inst, Sch Med, Div Canc & Stem Cells, Nottingham, England
[4] Univ Nottingham, Sch Vet Med & Sci, Nottingham, England
[5] Nottingham Trent Univ, Div Life Sci, Nottingham, England
来源：
JOURNAL OF PATHOLOGY | 2023年 / 261卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3
引用
收藏
页码：S9 / S9
页数：1
相关论文
共 50 条
  • [1] Differential response of HER2-positive breast cancer to anti-HER2 therapy based on HER2 protein expression level
    Atallah, N. M.
    Alsaleem, M.
    Toss, M. S.
    Mongan, N. P.
    Rakha, E.
    BRITISH JOURNAL OF CANCER, 2023, 129 (10) : 1692 - 1705
  • [2] Differential response of HER2-positive breast cancer to anti-HER2 therapy based on HER2 protein expression level
    N. M. Atallah
    M. Alsaleem
    M. S. Toss
    N. P. Mongan
    E. Rakha
    British Journal of Cancer, 2023, 129 : 1692 - 1705
  • [3] HER2Δ16 expression in HER2-positive breast cancer
    De Yao, Jocelyn Torres
    Sun, Danyu
    Galehouse, Donna
    Shorten, Scott
    Haller, Nairmeen
    Rehmus, Esther Hoogland
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [4] HER2Δ16 expression in HER2-positive breast cancer
    De Yao, Jocelyn Torres
    Sun, Danyu
    Galehouse, Donna
    Shorten, Scott
    Haller, Nairmeen Awad
    Rehmus, Esther Hoogland
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (26)
  • [5] Quantitative measurements of HER2 expression and HER2: HER2 dimerization identify subgroups of HER2 positive metastatic breast cancer patients with different probabilities of response to trastuzumab treatment
    Huang, W.
    Lipton, A.
    Leitzel, K.
    Ali, S. M.
    Fuchs, E. M.
    Weidler, J.
    Chappey, C.
    Sperinde, J.
    Tan, Y.
    Jin, X.
    Paquet, A.
    Winston, J.
    Petropoulos, C.
    Kostler, W. J.
    Bates, M.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S86 - S86
  • [6] HER2 positive breast cancer
    Gianni, Luca
    Bianchini, Giampaolo
    CANCER RESEARCH, 2023, 83 (05)
  • [7] Salivary expression of soluble HER2 in breast cancer patients with positive and negative HER2 status
    Laidi, Fatna
    Bouziane, Amal
    Lakhdar, Amina
    Khabouze, Samira
    Rhrab, Brahim
    Zaoui, Fatima
    ONCOTARGETS AND THERAPY, 2014, 7 : 1285 - 1289
  • [8] HER2 status in breast cancer patients: A comparison between borderline positive HER2 and strongly positive HER2 tumors
    Huszno, J.
    Nowara, E.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S137 - S137
  • [9] HER2 Gene Protein Assay Is Useful to Determine HER2 Status and Evaluate HER2 Heterogeneity in HER2 Equivocal Breast Cancer
    Hou, Yanjun
    Nitta, Hiroaki
    Li, Zaibo
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2017, 147 (01) : 89 - 95
  • [10] Association Between the HER2 Protein Expression Level and the Efficacy of Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer
    Yan, Hui
    Xiao, Hui
    Zhu, Jiujun
    Zhang, Jingyang
    Liu, Zhenzhen
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 12715 - 12722
12345